Valsartan/Amlodipine/Chlorthalidone

缬沙坦/氨氯地平/氯噻酮

Report date: 2024/05/17 20:00:39

Base Information

Drug NameValsartan/Amlodipine/Chlorthalidone
Drug Alias NameAJU-C52AJU-C52L
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAngiotensin II Receptor Type 1 antagonistsVoltage-gated calcium channel blockersThiazide-sensitive sodium-chloride cotransporter inhibitors
TargetsAngiotensin II Receptor Type 1Voltage-gated calcium channelThiazide-sensitive sodium-chloride cotransporter
Therapy Area/IndicationsEssential Hypertension
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsYes ValsartanAmlodipineChlorthalidone
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesAju Pharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAju Pharm Co Ltd
Inactive CompaniesN/A
Active IndicationsEssential Hypertension
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A